Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renate Starr

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2015
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent GlioblastomaChristine E Brown, Behnam Badie, Michael E Barish, et al.
Frontiers in Immunology|March 7, 2024
Targeting Wnt signaling for improved glioma immunotherapyMargarita Gutova, Jonathan C Hibbard, Eric Ma, et al.
Science Translational Medicine|March 6, 2020
Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastomaDongrui Wang, Renate Starr, Wen-Chung Chang, et al.
Cancer Discovery|April 10, 2021
IFNγ Is Critical for CAR T Cell-Mediated Myeloid Activation and Induction of Endogenous ImmunityDarya Alizadeh, Robyn A Wong, Sharareh Gholamin, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Meditope-Enabled Chimeric Antigen Receptors Facilitate Plug-and-Play Control of T CellsCheng-Fu Kuo, Zhen Tong, Yi-Chiu Kuo, et al.
Cell Reports. Medicine|August 16, 2025
Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safetyMichael E Barish, Maryam Aftabizadeh, Jonathan Hibbard, et al.
Cancer Discovery|December 17, 2020
CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based TherapiesDongrui Wang, Briana C Prager, Ryan C Gimple, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Overcoming myeloid-driven resistance to CAR T therapy by targeting SPP1Sharareh Gholamin, Heini M Natri, Yuqi Zhao, et al.
Cell Stem Cell|April 8, 2022
3D-organoid culture supports differentiation of human CAR<sup>+</sup> iPSCs into highly functional CAR T cellsZhiqiang Wang, Helen P McWilliams-Koeppen, Hernan Reza, et al.
The New England Journal of Medicine|December 29, 2016
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell TherapyChristine E Brown, Darya Alizadeh, Renate Starr, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2015
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent GlioblastomaChristine E Brown, Behnam Badie, Michael E Barish, et al.
Frontiers in Immunology|March 7, 2024
Targeting Wnt signaling for improved glioma immunotherapyMargarita Gutova, Jonathan C Hibbard, Eric Ma, et al.
Science Translational Medicine|March 6, 2020
Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastomaDongrui Wang, Renate Starr, Wen-Chung Chang, et al.
Cancer Discovery|April 10, 2021
IFNγ Is Critical for CAR T Cell-Mediated Myeloid Activation and Induction of Endogenous ImmunityDarya Alizadeh, Robyn A Wong, Sharareh Gholamin, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Meditope-Enabled Chimeric Antigen Receptors Facilitate Plug-and-Play Control of T CellsCheng-Fu Kuo, Zhen Tong, Yi-Chiu Kuo, et al.
Cell Reports. Medicine|August 16, 2025
Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safetyMichael E Barish, Maryam Aftabizadeh, Jonathan Hibbard, et al.
Cancer Discovery|December 17, 2020
CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based TherapiesDongrui Wang, Briana C Prager, Ryan C Gimple, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Overcoming myeloid-driven resistance to CAR T therapy by targeting SPP1Sharareh Gholamin, Heini M Natri, Yuqi Zhao, et al.
Cell Stem Cell|April 8, 2022
3D-organoid culture supports differentiation of human CAR<sup>+</sup> iPSCs into highly functional CAR T cellsZhiqiang Wang, Helen P McWilliams-Koeppen, Hernan Reza, et al.
The New England Journal of Medicine|December 29, 2016
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell TherapyChristine E Brown, Darya Alizadeh, Renate Starr, et al.
Pageof 4